European Journal of Internal Medicine
Volume 20, Issue 1 , Pages 3-8, January 2009

Physician's guide to pharmacovigilance: Terminology and causality assessment

  • H.S. Rehan

      Affiliations

    • Department of Pharmacology, Lady Hardinge Medical College, New Delhi 110001, India
    • National Pharmacovigilance Programme, Lady Hardinge Medical College, New Delhi 110001, India
  • ,
  • Deepti Chopra

      Affiliations

    • Department of Pharmacology, Lady Hardinge Medical College, New Delhi 110001, India
    • Corresponding Author InformationCorresponding author. Tel.: +91 9818710237.
  • ,
  • Ashish Kumar Kakkar

      Affiliations

    • Department of Pharmacology, Lady Hardinge Medical College, New Delhi 110001, India

Received 16 August 2007; received in revised form 29 March 2008; accepted 25 April 2008. published online 16 June 2008.

Abstract 

Adverse drug events can range from mild to life threatening reactions resulting in inconvenience or serious morbidity and mortality besides being a financial burden on the society. However clinicians often do not recognize this drug related harm. The terms used to describe these events with medication use cause much confusion. Moreover manifestations of adverse drug reactions can be non-specific making it difficult to differentiate from current illness. To determine the likelihood of relationship between the drug and the event assessment of causality is done. The purpose of this article is to review and clarify the terms encompassing the discipline of pharmacovigilance and also to outline the steps in causality assessment with the help of an actual case report.

Keywords: Adverse drug events, Drug related harm, Pharmacovigilance, Causality assessment

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0953-6205(08)00129-5

doi:10.1016/j.ejim.2008.04.019

European Journal of Internal Medicine
Volume 20, Issue 1 , Pages 3-8, January 2009